Clinical Response in Plaque Psoriasis Patients Switching from Etanercept to Certolizumab Pegol in a Phase 3, Randomized, Controlled Study

2018

Abstract not available. Disclosures: Study sponsored by Dermira. Copyright 2018 SKIN

Keywords:

Correction
Source
Cite
Save
Machine Reading By IdeaReader

0

References

1

Citations